"I see today’s announcement as further evidence that Teva will likely settle the Copaxone patent case with NVS/MNTA if the FDA approves NVS/MNTA’s ANDA before the litigation has run its course."
What type of settlement would transpire? Would TEVA give MNTA a one time payment for not entering the market until a set time?